CLARUS THERAPEUTICS HOLDINGS, INC. false0001817944P3YThe effect of the convertible notes on the numerator for the year ended December 31, 2020...
Table of Contents As Filed Pursuant to Rule 424(b)(3) Registration No. 333-264231...
Table of Contents Prospectus Supplement No. 2 ...
false--12-31Q10001817944Warrants to purchase one share of common stock at an exercise price of $11.50. Relates to activity associated with the...
false 0001817944 0001817944 2022-05-16 2022-05-16 0001817944 us-gaap:CommonStockMember 2022-05-16 2022-05-16 0001817944 us-gaap:WarrantMember...
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...
Prospectus Supplement No. 1 Filed Pursuant to...
Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-259915 ...
false 0001817944 0001817944 2022-04-24 2022-04-24 0001817944 crxt:CommonStockParValue0.0001PerShare2Member 2022-04-24 2022-04-24 0001817944...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
Table of Contents As Filed Pursuant to Rule 424(b)(4) Registration No. 333-264231 Registration...
Table of Contents As filed with the Securities and Exchange Commission on April 25, 2022...
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange...
false 0001817944 0001817944 2022-04-12 2022-04-12 0001817944 crxt:CommonStockParValue0.0001PerShareMember 2022-04-12 2022-04-12 0001817944...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.